Rubinstein-Taybi syndrome 2 with cerebellar abnormality and neural tube defect.
CREB-Binding Protein
/ genetics
Cerebellum
/ abnormalities
Child, Preschool
E1A-Associated p300 Protein
/ genetics
Exons
Frameshift Mutation
Genetic Association Studies
Genetic Testing
Genome, Human
Genotype
Heterozygote
High-Throughput Nucleotide Sequencing
Humans
Male
Mutation
Neural Tube Defects
/ genetics
Rubinstein-Taybi Syndrome
/ genetics
Sequence Deletion
/ genetics
Journal
Clinical dysmorphology
ISSN: 1473-5717
Titre abrégé: Clin Dysmorphol
Pays: England
ID NLM: 9207893
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
pubmed:
23
2
2019
medline:
18
12
2019
entrez:
22
2
2019
Statut:
ppublish
Résumé
Rubinstein-Taybi syndrome (RSTS) is a rare dominant disorder with intellectual disability, postnatal growth deficiency, and multiple congenital anomalies. Approximately 50-70% of the patients have a mutation in the CREBBP gene (RSTS1) and 5-10% display an EP300 gene mutation (RSTS2). Craniospinal abnormalities such as microcranium, scoliosis, and lordosis are frequent findings in RSTS1, but malformations of the brain or spinal cord are seen only occasionally. Here, we report on a 3-year-old boy with facial abnormalities of RSTS, broad thumbs and halluces, developmental delay, autistic features, cerebellar underdevelopment, and a neural tube defect. Molecular diagnostic of the CREBBP and EP300 genes showed a heterozygous 17-bp deletion (c.5698_5714del AAGGCAGCAGGCCAGGT) in exon 31 of the EP300 gene. Findings underline that small (hypoplastic) cerebellum and neural tube defects belong to the phenotypic spectrum not only of RSTS1 but also of RSTS2. Based on the literature and this observation, we recommend that each individual with RSTS2 should be closely evaluated for neural axis and craniovertebral junction anomalies, and where appropriate, neuroimaging studies should be considered. Our frequency estimate of ~ 6% occult or overt neural tube defects in RSTS2 could represent an underestimate.
Identifiants
pubmed: 30789376
doi: 10.1097/MCD.0000000000000262
pmc: PMC6553355
doi:
Substances chimiques
CREB-Binding Protein
EC 2.3.1.48
CREBBP protein, human
EC 2.3.1.48
E1A-Associated p300 Protein
EC 2.3.1.48
EP300 protein, human
EC 2.3.1.48
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
137-141Références
Am J Dis Child. 1963 Jun;105:588-608
pubmed: 13983033
Am J Hum Genet. 2005 Apr;76(4):572-80
pubmed: 15706485
Am J Med Genet A. 2005 Jun 1;135(2):130-3
pubmed: 15832359
Hum Genet. 2005 Sep;117(5):485-93
pubmed: 16021471
Eur J Hum Genet. 2006 Sep;14(9):981-5
pubmed: 16868563
J Neurosurg. 2006 Oct;105(4 Suppl):261-4
pubmed: 17328274
Am J Med Genet A. 2010 Jan;152A(1):181-4
pubmed: 20014264
Am J Med Genet A. 2011 Nov;155A(11):2766-70
pubmed: 21932317
Childs Nerv Syst. 2012 Dec;28(12):2163-8
pubmed: 22914921
Am J Med Genet A. 2014 Sep;164A(9):2300-9
pubmed: 24989455
PLoS One. 2015 Jul 14;10(7):e0132468
pubmed: 26171964
Neuroradiol J. 2015 Jun;28(3):238-53
pubmed: 26246090
Am J Med Genet A. 2016 Dec;170(12):3069-3082
pubmed: 27648933
Clin Dysmorphol. 2017 Jul;26(3):170-174
pubmed: 28027063
Am J Med Genet A. 2018 Apr;176(4):862-876
pubmed: 29460469
Nature. 1995 Jul 27;376(6538):348-51
pubmed: 7630403